Chime Biologics
Premium PartnerIs this your company? Claim this profile
Drug Product
Advanced Modalities
Analytical & Bioanalytical Services
Regulatory, Tech Transfer & Support Services
Clinical Trial Supply & Logistics
Company Overview
About
Chime Biologics is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Quality Control, Stability Testing, Method Development
Therapeutic Areas
Immunology
Rheumatology
Quick Facts
HQ:China
Founded:1997
Employees:1,461
Capabilities & Services
Core Capabilities
- Peptide Synthesis
- Small Molecule API
- Formulation Development
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Inhalation
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Pilot Scale
Phase I Clinical Trials
Clinical
Markets Served
Asia-Pacific
Regulatory Approvals
Drug Approval XPE7RC
PMDA · #APR-JKCJQNSQ · 2021-02-01
Drug Approval XPKH5E
FDA · #APR-9QWNNJNM · 2022-05-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-I9GPFZIE
Issued: 2020-07-01
Expires: 2025-08-12
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-OOUS8TWJ
Issued: 2020-03-13
Expires: 2025-07-22
Loading CDMO intelligence...
Key facts about Chime Biologics
- Chime Biologics is headquartered in China.
- Chime Biologics was founded in 1997.
- Chime Biologics has 1,461 employees.
- Chime Biologics's capabilities include Peptide Synthesis, Small Molecule API and Formulation Development.
Find CDMOs like Chime Biologics
Directory pages this company appears in, each with the full list of matching manufacturers.